ArticleFrontiers in pediatrics2024
Lung ultrasound to evaluate the outcome and prognosis of transient tachypnea of the newborn.
Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objectives: Transient tachypnea of the newborn (TTN) is generally self-limiting. The increasing incidence of severe cases and lack of comprehensive studies on its clinical outcomes and influencing factors highlight the need for improved diagnostic and monitoring tools. This study aimed to assess the lung ultrasonographic features, recovery durations, and factors influencing TTN. Methods: Two hundred neonates with wet lungs were selected as the TTN group and divided into mild (132/200) and severe (68/200) groups. Two hundred neonates without pulmonary disease served as controls. The acute-phase lung ultrasonographic features of the two groups were compared. According to the clinical recovery duration, TTN group was divided into group A (<5 days, 191/200) and group B (≥5 days, 9/200). Univariate and multivariate logistic regression analyses were used to analyze the relationship between clinically relevant factors and the recovery time. Results: The time that was required for the 200 neonates to fully recover without symptoms was 2.3 ± 1.33 days. The average clinical recovery durations of neonates with mild illness, those who required non-invasive ventilation, and those who required invasive ventilation were 1.42 ± 0.50, 3.36 ± 0.51, and 6.00 ± 1.12 days, respectively. The differences between the groups were significant ( Conclusion: The lung ultrasonographic signs differed based on the degree of wet lungs. Moreover, type II respiratory failure, ARDS, PPHN, and heart failure are important factors prolonging the course of TTN in neonates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.